FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002587079> ?p ?o ?g. }

• W2002587079 endingPage "324" @default.
• W2002587079 startingPage "317" @default.
• W2002587079 abstract "OBJECTIVE The childhood obesity epidemic has been accompanied by an increasing prevalence of type 2 diabetes (T2D), particularly in minority children. Twenty to thirty percent of obese youth have “prediabetes,” a precursor to diabetes marked by insulin resistance, β-cell dysfunction, and impaired glucose tolerance. The Diabetes Prevention Program demonstrated that T2D could be prevented/delayed by intensive lifestyle modification in adults with prediabetes, but efficacy of similar interventions in youth has not been established. Therefore, we evaluated the effects of the Bright Bodies (BB) Healthy Lifestyle Program on 2-h oral glucose tolerance test (OGTT) glucose in comparison with adolescents receiving standard of care. RESEARCH DESIGN AND METHODS A parallel-group randomized controlled trial comparing BB with standard clinical care (CC) in obese adolescents (10–16 years old, Tanner stage &gt;2) with elevated OGTT 2-h blood glucose (130–199 mg/dL) from a racially/ethnically diverse population. OGTTs, including cardiovascular and anthropometric assessments, were conducted at baseline and 6 months. Children attended BB twice per week for exercise and nutrition/behavior modification, and the CC group received CC from their pediatrician. Primary outcome was change in 2-h OGTT glucose and percentage conversion from elevated 2-h blood glucose to nonelevated (&lt;130 mg/dL) 2-h blood glucose. Changes in outcomes were compared between groups using an ANCOVA, with adjustment for baseline outcome and multiple imputation for missing data. RESULTS Reductions in 2-h glucose were more favorable in BB compared with CC (−27.2 vs. −10.1 mg/dL; difference = −17.1, 95% CI; P = 0.005). Moreover, greater conversion to &lt;130 mg/dL 2-h glucose occurred in BB than CC (P = 0.003), and other insulin sensitivity indices were significantly improved. CONCLUSIONS Compared with standard of care, the Yale BB Program is a more effective means of reducing the risk of T2D in obese adolescents with elevated 2-h glucose levels." @default.
• W2002587079 created "2016-06-24" @default.
• W2002587079 creator A5002265183 @default.
• W2002587079 creator A5003503904 @default.
• W2002587079 creator A5018634594 @default.
• W2002587079 creator A5023870801 @default.
• W2002587079 creator A5033435676 @default.
• W2002587079 creator A5037107017 @default.
• W2002587079 creator A5043366249 @default.
• W2002587079 creator A5045882237 @default.
• W2002587079 creator A5053610259 @default.
• W2002587079 creator A5053895234 @default.
• W2002587079 creator A5074207806 @default.
• W2002587079 creator A5081537807 @default.
• W2002587079 creator A5089282370 @default.
• W2002587079 date "2014-01-11" @default.
• W2002587079 modified "2023-10-17" @default.
• W2002587079 title "Reversal of Early Abnormalities in Glucose Metabolism in Obese Youth: Results of an Intensive Lifestyle Randomized Controlled Trial" @default.
• W2002587079 cites W1538553036 @default.
• W2002587079 cites W1666284134 @default.
• W2002587079 cites W1963830586 @default.
• W2002587079 cites W1984206010 @default.
• W2002587079 cites W2000642155 @default.
• W2002587079 cites W2014004380 @default.
• W2002587079 cites W2027742693 @default.
• W2002587079 cites W2032425836 @default.
• W2002587079 cites W2037591251 @default.
• W2002587079 cites W2048018927 @default.
• W2002587079 cites W2054606580 @default.
• W2002587079 cites W2067262787 @default.
• W2002587079 cites W2067732355 @default.
• W2002587079 cites W2080373048 @default.
• W2002587079 cites W2081270681 @default.
• W2002587079 cites W2106221382 @default.
• W2002587079 cites W2109351685 @default.
• W2002587079 cites W2121328463 @default.
• W2002587079 cites W2126465692 @default.
• W2002587079 cites W2133795831 @default.
• W2002587079 cites W2136252974 @default.
• W2002587079 cites W2154948456 @default.
• W2002587079 cites W2158822657 @default.
• W2002587079 cites W2160234571 @default.
• W2002587079 cites W2161626145 @default.
• W2002587079 cites W2163418596 @default.
• W2002587079 cites W4241883936 @default.
• W2002587079 doi "https://doi.org/10.2337/dc13-1571" @default.
• W2002587079 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3898759" @default.
• W2002587079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24062325" @default.
• W2002587079 hasPublicationYear "2014" @default.
• W2002587079 type Work @default.
• W2002587079 sameAs 2002587079 @default.
• W2002587079 citedByCount "103" @default.
• W2002587079 countsByYear W20025870792014 @default.
• W2002587079 countsByYear W20025870792015 @default.
• W2002587079 countsByYear W20025870792016 @default.
• W2002587079 countsByYear W20025870792017 @default.
• W2002587079 countsByYear W20025870792018 @default.
• W2002587079 countsByYear W20025870792019 @default.
• W2002587079 countsByYear W20025870792020 @default.
• W2002587079 countsByYear W20025870792021 @default.
• W2002587079 countsByYear W20025870792022 @default.
• W2002587079 countsByYear W20025870792023 @default.
• W2002587079 crossrefType "journal-article" @default.
• W2002587079 hasAuthorship W2002587079A5002265183 @default.
• W2002587079 hasAuthorship W2002587079A5003503904 @default.
• W2002587079 hasAuthorship W2002587079A5018634594 @default.
• W2002587079 hasAuthorship W2002587079A5023870801 @default.
• W2002587079 hasAuthorship W2002587079A5033435676 @default.
• W2002587079 hasAuthorship W2002587079A5037107017 @default.
• W2002587079 hasAuthorship W2002587079A5043366249 @default.
• W2002587079 hasAuthorship W2002587079A5045882237 @default.
• W2002587079 hasAuthorship W2002587079A5053610259 @default.
• W2002587079 hasAuthorship W2002587079A5053895234 @default.
• W2002587079 hasAuthorship W2002587079A5074207806 @default.
• W2002587079 hasAuthorship W2002587079A5081537807 @default.
• W2002587079 hasAuthorship W2002587079A5089282370 @default.
• W2002587079 hasBestOaLocation W20025870791 @default.
• W2002587079 hasConcept C126322002 @default.
• W2002587079 hasConcept C134018914 @default.
• W2002587079 hasConcept C168563851 @default.
• W2002587079 hasConcept C2777180221 @default.
• W2002587079 hasConcept C2777185836 @default.
• W2002587079 hasConcept C2777391703 @default.
• W2002587079 hasConcept C2779668308 @default.
• W2002587079 hasConcept C2780609358 @default.
• W2002587079 hasConcept C2908647359 @default.
• W2002587079 hasConcept C555293320 @default.
• W2002587079 hasConcept C61427482 @default.
• W2002587079 hasConcept C71924100 @default.
• W2002587079 hasConcept C99454951 @default.
• W2002587079 hasConceptScore W2002587079C126322002 @default.
• W2002587079 hasConceptScore W2002587079C134018914 @default.
• W2002587079 hasConceptScore W2002587079C168563851 @default.
• W2002587079 hasConceptScore W2002587079C2777180221 @default.
• W2002587079 hasConceptScore W2002587079C2777185836 @default.
• W2002587079 hasConceptScore W2002587079C2777391703 @default.
• W2002587079 hasConceptScore W2002587079C2779668308 @default.
• W2002587079 hasConceptScore W2002587079C2780609358 @default.

• next